Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPSQ2FY26 Operational PAT at ₹1,403m and EPS at ₹15.2, Grew 84% YoY".
Press Release Oct 31 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Intimation on Board Meeting scheduled for Oct 31, 2025
- Press Release Oct 17 2025
- Kenox Enters into Strategic Product Development Partnership with Strides
- Press Release Sep 08 2025
- Press Release Jul 29 2025
Later from Strides Pharma Science
- Press Release Jan 30 2026
- Strides Pharma Science Ltd Press Release Feb 05 2026
- Press Release (Revised) Feb 05 2026
- Press Release Mar 17 2026
- Press Release May 18 2026
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science